Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting ...

: Written by: Drug News Feed; Category: Drug News; Published: 09 March 2021; Hits: 328

A 3-month buprenorphine released injectable designed to be dosed subcutaneously for treating opioid use disorder (OUD). The Buprenorphine release ...

Read more https://www.google.com/url?rct=j&sa=t&url=https://www.prnewswire.com/news-releases/breaking-the-cycle-of-opioid-addiction-alar-presents-positive-interim-results-of-long-acting-buprenorphine-injectable-ala-1000-in-opioid-dependent-patients-301243248.html&ct=ga&cd=CAIyHGUxNmUxOWQ1ZmFmZjE2ZDU6Y29tOmVuOlVTOlI&usg=AFQjCNHeLlZoaHturh7_7BLyuwbv6Y65sw